Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. - Wikidata - awgldk - TriplyDB

Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo.

Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo.

http://www.wikidata.org/entity/Q37331535

about

Microvesicles as a potential biomarker of neoplastic diseases and their role in development and progression of neoplasm Microparticles as Biomarkers of Blood Coagulation in Cancer Biomolecular markers of cancer-associated thromboembolism Activation of blood coagulation in cancer: implications for tumour progression Pyruvate kinase type M2 promotes tumour cell exosome release via phosphorylating synaptosome-associated protein 23 Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis.Shen-Cao granules formulated based on traditional Chinese medicine alleviates bone marrow suppression caused by platinum-based anticancer reagents.Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells.Microparticle-mediated transfer of the viral receptors CAR and CD46, and the CFTR channel in a CHO cell model confers new functions to target cells.Prognostic significance of preoperative mean platelet volume in resected non-small-cell lung cancer Extracellular vesicles as prospective carriers of oncogenic protein signatures in adult and paediatric brain tumours.Arterial and venous thrombosis in cancer patients Role of tissue factor in venous thrombosis.Adaptive mutations in the genomes of enterovirus 71 strains following infection of mouse cells expressing human P-selectin glycoprotein ligand-1.Microparticles in hemostasis and thrombosis.Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome.Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer.The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis.New insights into the mechanisms of venous thrombosis.Cancer Cell-Derived Extracellular Vesicles Are Associated with Coagulopathy Causing Ischemic Stroke via Tissue Factor-Independent Way: The OASIS-CANCER Study.Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice.Microvesicles as potential ovarian cancer biomarkers.Venous thrombosis and cancer: from mouse models to clinical trials.Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study)Thrombin inhibition and cyclophosphamide synergistically block tumor progression and metastasis Simulated thrombin responses in venous valves.The prothrombotic activity of cancer cells in the circulation The Hemostasis Apparatus in Pancreatic Cancer and Its Importance beyond Thrombosis.Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.Prognostic value of hematological parameters in patients undergoing esophagectomy for esophageal squamous cell carcinoma.Standardizing a simpler, more sensitive and accurate tail bleeding assay in mice.Cancer and Thrombosis: The Platelet Perspective.FVIIa as used pharmacologically is not TF dependent in hemophilia B mice Thrombin inhibition and cisplatin block tumor progression in ovarian cancer by alleviating the immunosuppressive microenvironment.The multivalent activity of the tissue factor-thrombin pathway in thrombotic and non-thrombotic disorders as a target for therapeutic intervention.Tissue factor-bearing microparticles and thrombus formation.Microvesicles as mediators of intercellular communication in cancer--the emerging science of cellular 'debris'.Tissue factor and cell signalling in cancer progression and thrombosis.Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis.

P2860

Q26768704-55B7D8CE-C83F-487E-944B-C525F3C163C8 Q26783691-8791A121-A058-4C97-A0F4-71281A47C2B0 Q26865716-ABA1DA1E-006A-473D-9DAB-BA897C1671E2 Q26998742-74ABAFD6-919B-4777-9A05-B2E1F5314C07 Q30834736-F3F05654-EE26-4B67-8E98-6AF4C23BC928 Q33401969-E807D8DE-8077-480D-B0C9-EE3027CFE2D8 Q33441730-49DA6AF7-636F-405C-A8B1-52876CF4F2F5 Q34146011-BF5FCD73-8290-4BD5-8ED5-106D648D7224 Q34533653-6038F247-B621-4743-9DF6-E5CC333DB1DC Q34607279-60DEC37A-C757-4B0C-B076-743B7FA145AB Q34625129-CC9E787D-9CA7-49F2-B77C-5DC7F177BAF5 Q34635182-44AFB720-3FA0-4EAC-B7A2-C2C83976CFF8 Q34795476-BCEFC2B1-85C6-44F8-90B9-6E2423E27CFD Q34837231-AE8131EC-3E6C-4D08-9966-DCD0C4634F95 Q35131040-A0383266-2CFE-4376-87F0-3AF99AF407E3 Q35483514-1C06C5C4-81CF-4891-B0B8-1C14B74A6AE0 Q35832620-4ED8C893-3641-4886-AF01-A265CFB033CA Q36015233-6BCBE99C-3F26-4C43-BCCE-2BFC44F1A5CE Q36051099-735A0F56-874C-4F43-B814-921FFC470E3D Q36068279-916804C5-F57A-44BA-BDC1-0E6C3A33BDD6 Q36079937-CA59F9C5-A87F-4296-902B-82A83F2C0553 Q36470049-313CF455-C8C1-4748-950A-DB39FB26EBF2 Q36635032-5566BBB1-206E-4DDE-83CA-B01CA77BE057 Q36636558-98D6753A-3D15-4152-BF27-960B35B9228A Q36721696-AF49A8C5-5FD7-4CA3-A5EE-353D03BF731F Q36843779-561AF64C-D4FD-4729-86BF-7DE954250B37 Q37018760-CCE2D66F-0AE6-4C86-9694-78EF51268F28 Q37088087-FFB31D3A-C02A-48A3-85DA-6E1E536171B5 Q37129768-0E223365-8E1A-4897-9CD2-7F54E5B7DEB8 Q37169096-4D61CD2A-52D5-4D7A-86FB-669406F8199A Q37321950-A9D9BBD3-7614-466C-9946-2A5BA6D6038B Q37527691-E4E692D9-9383-466F-B635-15762F5DEAB2 Q37558436-3A6412AB-D45A-46F2-8367-6EA21BB3C4C1 Q37636989-81D82470-E931-4B7C-9E06-E263AEE05503 Q37709136-4FA90A64-CAB9-4174-87FC-687064EFA6D8 Q37808230-390AAA57-68E6-4D90-B8A3-4CCF6DC3D117 Q37830928-5EFDA5DC-4E6B-4636-A9D7-D68438F596EF Q37841221-843B25A6-4995-4A90-9149-4F23AF89917E Q37903955-1F5F7F42-B0D8-4194-B293-A094F5D6FBBF Q37922118-C5064C9D-83E1-4F33-ADB2-4BDD7C4CADB1

P2860

Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo.

http://www.wikidata.org/entity/Q37331535

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 August 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cancer cell-derived microparti ...... te thrombus formation in vivo.

@en

Cancer cell-derived microparti ...... te thrombus formation in vivo.

@nl

type

label

Cancer cell-derived microparti ...... te thrombus formation in vivo.

@en

Cancer cell-derived microparti ...... te thrombus formation in vivo.

@nl

prefLabel

Cancer cell-derived microparti ...... te thrombus formation in vivo.

@en

Cancer cell-derived microparti ...... te thrombus formation in vivo.

@nl

P1433

Q37331535-B30FDD56-CE0F-4925-A0FB-52CC9B43CE65

P1476

Q37331535-E9BB3DDB-4041-4207-97A1-911A6606F73D

P2093

Q37331535-0B75F0C0-B087-4DB7-B617-EA7C3C69113F

Q37331535-1416055F-D2A0-4E64-80FD-088C9E6CCCF3

Q37331535-158787E3-6BFA-4B45-932E-9FB50FDCAB05

Q37331535-2C05DE40-0602-4150-9519-D179F5874C1B

P2860

Q37331535-086D42A4-9E9F-44C0-9FC9-F91A3E651ECE

Q37331535-0CBDBD2C-BB9C-4AE3-A7D9-A91A8E83AB54

Q37331535-0F5A2521-6D96-4D85-9E99-B43232EB755D

Q37331535-100E51B8-079C-44C8-83D8-57151AE9EA0A

Q37331535-21FABEE1-B1B1-4686-ADB1-AB3D80EEDD6D

Q37331535-26BAEBD8-9C1C-42E9-ACA4-CBA6EADD0404

Q37331535-2832F171-80E3-4B60-A65B-61C0C2505887

Q37331535-31D24705-10F1-48E5-AAAB-7F0A409054FF

Q37331535-4C762303-9136-43B9-96B9-4C6872510FBA

Q37331535-50F190B6-53F7-4937-8764-FB7CA5A60237

P304

Q37331535-4EAEBBB3-99DD-494F-904E-67556431BC9A

P31

Q37331535-F0C0FE49-5653-440D-A94B-920E6C6FB0EC

P356

Q37331535-F77D4891-11BE-4277-97D0-4FF75A47F039

P407

Q37331535-FD461278-0587-4BB0-B49E-12A3FCFE958A

P433

Q37331535-CF762657-6F73-4E91-B2F6-B8CA32824C92

P478

Q37331535-612CB6CC-E34C-4A5A-AAC9-35B8DDC8C1E4

P50

Q37331535-6460D4C0-6705-4E9D-A102-15AC797343E2

Q37331535-BDDD7EE6-DB1B-4B76-94DB-DE37574677DA

P577

Q37331535-7269A114-EF77-4179-B901-084F24BF7D03

P5875

Q37331535-D564A13B-33D2-408C-A646-F87033D31A94

P698

Q37331535-0DA02A1F-920D-4F00-9999-D6607625A6AF

P932

Q37331535-0AF16D4E-A520-494C-A0FE-D625790E3526

P356

P1433

Journal of Experimental Medicine

P1476

Cancer cell-derived microparti ...... ate thrombus formation in vivo

@en

P2093

Dominique Lombardo

http://www.w3.org/2001/XMLSchema#string

Françoise Dignat-George

http://www.w3.org/2001/XMLSchema#string

Laurence Panicot-Dubois

http://www.w3.org/2001/XMLSchema#string

Romaric Lacroix

http://www.w3.org/2001/XMLSchema#string

P2860

Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo

Cancer-associated thrombosis

Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model

Microvesicle-associated tissue factor and Trousseau's syndrome

Plasma fibronectin promotes thrombus growth and stability in injured arterioles.

Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin.

Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis.

Circulating microparticles: pathophysiology and clinical implications.

Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation.

Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features.

P304

1913-1927

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20082297

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

206

http://www.w3.org/2001/XMLSchema#string

P50

Christophe Dubois

P577

2009-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26728907

http://www.w3.org/2001/XMLSchema#string

P698

19667060

http://www.w3.org/2001/XMLSchema#string

P932

2737159

http://www.w3.org/2001/XMLSchema#string